Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-SC003986-1
Host Cell : HeLa Size : >1x106 frozen cells/vial
| Cat. No. | CSC-SC003986-1 |
| Description | This cell line is engineered to stably express human cytochrome P450 family 4 subfamily Z member 1 (CYP4Z1) in CHO-K1 cells. |
| Target Gene | CYP4Z1 |
| Gene Species | Homo sapiens (Human) |
| Host Cell | HeLa |
| Host Cell Species | Homo sapiens (Human) |
| Applications |
1. Gene expression studies 2. Signaling pathway research 3. Drug screening and toxicology 4. Disease research |
| Size | >1x106 frozen cells/vial |
| Stability | Validated for at least 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Revival | Rapidly thaw cells in a 37°C water bath. Transfer contents into a tube containing pre-warmed media. Centrifuge cells and seed into a 25 cm2 flask containing pre-warmed media. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | CYP4Z1 cytochrome P450, family 4, subfamily Z, polypeptide 1 [ Homo sapiens ] |
| Gene Symbol | CYP4Z1 |
| Synonyms | CYP4A20 |
| Gene ID | 199974 |
| Uni Prot ID | Q86W10 |
| m RNA Refseq | NM_178134.2 |
| Protein Refseq | NP_835235.1 |
| Chromosome Location | 1p33 |
| Function | aromatase activity; electron carrier activity; heme binding; iron ion binding; |
| Pathway | cytochrome P450, organism-specific biosystem; metapathway biotransformation, organism-specific biosystem; |
The Human CYP4Z1 gene encodes a member of the cytochrome P450 family of enzymes, which are responsible for the metabolism of a wide range of endogenous and exogenous compounds, including drugs, toxins, and steroids. CYP4Z1, in particular, is involved in the metabolism of fatty acids and has been implicated in the regulation of lipid homeostasis and inflammation. Variations in CYP4Z1 expression or function can affect an individual's response to medications and susceptibility to certain diseases.
The HeLa cell line, which is derived from a human cervical carcinoma, has been modified to stably express the Human CYP4Z1 gene. This stable cell line provides a valuable tool for studying the role of CYP4Z1 in drug metabolism and its potential implications in pharmacokinetics and pharmacodynamics. Researchers can use the HeLa CYP4Z1 stable cell line to investigate the enzyme's catalytic activity, its regulation by various factors, and its interaction with other components of the cytochrome P450 system. This cell line also serves as a platform for drug metabolism studies and the development of personalized medicine strategies based on individual CYP4Z1 activity.
The Human CYP4Z1 Stable Cell Line - HeLa is a cell line derived from the human cervical carcinoma cell line HeLa, engineered to express the CYP4Z1 gene. This cell line has several applications in pharmacology and toxicology:
Drug Metabolism: CYP4Z1 is involved in the metabolism of various drugs, including some anti-inflammatory and anti-cancer agents. This cell line can be used to study the role of CYP4Z1 in drug metabolism and to predict drug-drug interactions.
Toxicity Studies: The expression of CYP4Z1 can help in understanding the metabolic activation of prodrugs and the formation of toxic metabolites, which is crucial for the safety assessment of new drugs.
Cancer Research: The HeLa cell line is a well-established model for cancer research, and the addition of CYP4Z1 can provide insights into the role of this enzyme in cancer biology, particularly in the context of drug resistance and tumor microenvironment.
A: The stable expression of the CYP4Z1 gene in the Human CYP4Z1 Stable Cell Line - HeLa is achieved by integrating the CYP4Z1 gene into the genome of HeLa cells, using selective markers and screening strategies to ensure its continuous expression. This technique typically involves the use of viral vectors, such as retroviruses or lentiviruses, along with antibiotic resistance genes as selection markers, thereby creating a cellular model for long-term study of CYP4Z1 function and drug metabolism characteristics.
A: The applications of the Human CYP4Z1 Stable Cell Line - HeLa in drug metabolism research include evaluating the metabolic properties of new drug candidates, studying the role of CYP4Z1 in drug metabolism, and exploring drug-drug interactions. This cell line provides a platform to simulate the metabolic processes in the human liver, which is crucial for predicting the metabolic fate and potential toxicity of drugs in the body.
A: The role of the Human CYP4Z1 Stable Cell Line - HeLa in personalized medicine is reflected in its ability to simulate the inter-individual differences in CYP4Z1 gene expression, which is significant for understanding individual drug responses and developing personalized treatment plans. With this cell line, scientists can study how CYP4Z1 gene polymorphisms affect drug metabolism, thereby providing more precise drug dosages and treatment regimens for patients.
A: The Human CYP4Z1 Stable Cell Line - HeLa provides an experimental platform for studying CYP4Z1 gene polymorphisms, allowing scientists to observe the impact of different genotypes on drug metabolism. This cell line helps reveal how genetic variations lead to changes in drug metabolism rates, which is significant for the assessment of drug safety and efficacy.
A: The role of the Human CYP4Z1 Stable Cell Line - HeLa in drug toxicity research is to provide a model for assessing the potential toxicity of drug metabolites. By monitoring the drug metabolism process and the resulting metabolites in the cells, researchers can better understand how these metabolites affect cell function, which is crucial for predicting potential side effects and toxicity of drugs.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
The Human CYP4Z1 Stable Cell Line - HeLa enables researchers to conduct specific drug screening to assess the selective inhibition or activation of CYP4Z1.
With the Human CYP4Z1 Stable Cell Line - HeLa, researchers can investigate the role of CYP4Z1 in drug metabolism pathways, which is crucial for new drug development.
The Human CYP4Z1 Stable Cell Line - HeLa provides an efficient CYP4Z1 protein expression system for enzymology and protein engineering research.
Using the Human CYP4Z1 Stable Cell Line - HeLa ensures consistency in experimental results, reducing the uncertainty due to experimental variability.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.